Stay updated on Melanoma Immunotherapy Clinical Trial

Sign up to get notified when there's something new on the Melanoma Immunotherapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Melanoma Immunotherapy Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been pushed back from June 2025 to July 2025. Additionally, the revision number has been updated from v2.16.3 to v2.16.4.
    Difference
    0.7%
    Check dated 2025-06-20T18:10:09.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.0%
    Check dated 2025-06-13T15:51:12.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The page has been updated to include a new version of a medical study citation, indicating a revision from v2.16.1 to v2.16.2.
    Difference
    0.2%
    Check dated 2025-06-06T09:25:55.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    0.6%
    Check dated 2025-05-30T00:16:18.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The page has been updated to reflect new definitions and assessments related to progression-free survival (PFS) and overall survival (OS), including changes in the time frames for these measures and the methodology for assessing health-related quality of life (HRQoL). Additionally, specific dates and version revisions have been added.
    Difference
    29%
    Check dated 2025-05-22T21:23:59.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The page has removed a citation regarding the overall survival with combined Nivolumab and Ipilimumab in advanced melanoma, which may affect the credibility and informational content of the page.
    Difference
    0.2%
    Check dated 2025-05-15T19:40:23.000Z thumbnail image

Stay in the know with updates to Melanoma Immunotherapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Melanoma Immunotherapy Clinical Trial page.